Clinical Trial Update: A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines [Phase 1]

View source ↗

Summary

Phase 1 study by the University of Oxford evaluating safety and immunogenicity of conserved mosaic HIV-1 vaccines; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Conserved Mosaic HIV-1 Vaccines

Snippet

Sponsor: University of Oxford | Conditions: HIV | Phase 1 | Status: COMPLETED | Results posted: 2024-09-03